Seaport Therapeutics director reports stock options
Seaport Therapeutics director Robert J. Hombach reported his holdings of stock options tied to the company’s common stock.
Rhea-AI Filing Summary
Seaport Therapeutics director Robert J. Hombach reported his holdings of stock options tied to the company’s common stock. He holds options covering 12,258 underlying shares at an exercise price of $10.31 per share that expire on February 23, 2036, and options covering 77,042 underlying shares at $7.39 per share that expire on March 2, 2035.
According to the vesting terms, one grant vests one-third of its underlying shares on March 25, 2026, with the balance vesting in 24 equal monthly installments, while another grant vests in full on February 24, 2027, in each case conditioned on his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
HOMBACH ROBERT J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 89,300 contracts (Direct)
Footnotes (2)
- F1. 1/3rd of the shares underlying this option vested and became exercisable on March 25, 2026, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F2. The shares underlying this option shall vest and become exercisable on February 24, 2027, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Option underlying shares: 12,258 shares
Exercise price: $10.31 per share
Option expiration: February 23, 2036
+5 more
8 metrics
Option underlying shares
12,258 shares
Underlying common stock for option at $10.31 exercise price
Exercise price
$10.31 per share
Stock option on Seaport Therapeutics common stock
Option expiration
February 23, 2036
Expiration date for $10.31 stock option grant
Option underlying shares
77,042 shares
Underlying common stock for option at $7.39 exercise price
Exercise price
$7.39 per share
Second stock option on Seaport Therapeutics common stock
Option expiration
March 2, 2035
Expiration date for $7.39 stock option grant
Initial vesting date
March 25, 2026
One-third of shares under one option vested on this date
Cliff vesting date
February 24, 2027
Second option grant vests and becomes exercisable on this date
Key Terms
Stock Option (Right to Buy), underlying security, exercise price, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"Security title is reported as "Stock Option (Right to Buy)" with common stock underlying."
underlying security financial
"Each option lists an underlying security title of common stock and underlying shares."
exercise price financial
"The options carry exercise prices of 10.3100 and 7.3900 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"One-third of the shares vested on March 25, 2026, with remaining shares vesting monthly thereafter."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The stock options have expiration dates in 2035 and 2036 respectively."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Seaport Therapeutics (SPTX) director Robert J. Hombach report in this Form 3?
He reported existing holdings of stock options on Seaport Therapeutics common stock. These options give rights to acquire shares at fixed exercise prices and specified expiration dates, with vesting tied to his continued service on the company’s board over future years.
What are the exercise prices of Robert Hombach’s Seaport Therapeutics (SPTX) options?
One option grant has an exercise price of $10.31 per share, while the other is priced at $7.39 per share. These exercise prices are the amounts he must pay per share to purchase Seaport Therapeutics common stock if he exercises the respective options.
When do Robert Hombach’s Seaport Therapeutics (SPTX) stock options expire?
One option grant expires on February 23, 2036, and the other expires on March 2, 2035. After these expiration dates, any unexercised portion of the options will lapse, meaning he would no longer have the right to buy those underlying shares.
How do the Seaport Therapeutics (SPTX) options granted to Robert Hombach vest over time?
For one grant, one-third of the underlying shares vested on March 25, 2026, and the remaining two-thirds vest in 24 equal monthly installments. A separate grant is scheduled to vest entirely on February 24, 2027, with both vestings dependent on his continued service.
Does this Seaport Therapeutics (SPTX) Form 3 show any recent stock purchases or sales by Robert Hombach?
The information describes holdings of stock options and their vesting schedules, not open-market share purchases or sales. Transaction summary data indicates no categorized buy or sell transactions, focusing instead on derivative option positions and their terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
